Daniel Cardenas

Stock Analyst at Janney Montgomery Scott

(2.13)
# 2,848
Out of 5,179 analysts
31
Total ratings
44.44%
Success rate
7.27%
Average return

Stocks Rated by Daniel Cardenas

S&T Bancorp
Jan 26, 2026
Upgrades: Buy
Price Target: $46
Current: $40.94
Upside: +12.36%
Community Financial System
Jan 13, 2026
Downgrades: Neutral
Price Target: n/a
Current: $56.80
Upside: -
Atlantic Union Bankshares
Oct 8, 2025
Initiates: Buy
Price Target: $42
Current: $34.79
Upside: +20.72%
Burke & Herbert Financial Services
Jul 10, 2025
Initiates: Buy
Price Target: $70
Current: $60.78
Upside: +15.18%
ChoiceOne Financial Services
Mar 3, 2025
Upgrades: Buy
Price Target: n/a
Current: $27.22
Upside: -
Norwood Financial
Jan 2, 2025
Initiates: Buy
Price Target: $31
Current: $28.87
Upside: +7.38%
ACNB Corporation
Nov 19, 2024
Initiates: Buy
Price Target: $53
Current: $47.25
Upside: +12.17%
First Commonwealth Financial
Jul 29, 2024
Downgrades: Neutral
Price Target: $16$19
Current: $17.26
Upside: +10.08%
Orrstown Financial Services
Jun 28, 2024
Initiates: Buy
Price Target: $32
Current: $34.98
Upside: -8.52%
Community Trust Bancorp
Mar 27, 2024
Initiates: Buy
Price Target: n/a
Current: $59.92
Upside: -
Initiates: Neutral
Price Target: $25
Current: $34.23
Upside: -26.96%
Initiates: Neutral
Price Target: $28
Current: $32.05
Upside: -12.64%
Initiates: Neutral
Price Target: $14
Current: $12.88
Upside: +8.70%
Initiates: Neutral
Price Target: $30
Current: $25.14
Upside: +19.33%
Initiates: Buy
Price Target: $27
Current: $22.33
Upside: +20.91%
Initiates: Neutral
Price Target: $19
Current: $15.49
Upside: +22.66%
Initiates: Neutral
Price Target: $15
Current: $12.42
Upside: +20.77%
Initiates: Neutral
Price Target: $91
Current: $119.45
Upside: -23.82%
Initiates: Neutral
Price Target: $37
Current: $33.37
Upside: +10.88%
Initiates: Outperform
Price Target: n/a
Current: $53.31
Upside: -
Upgrades: Outperform
Price Target: $18
Current: $38.29
Upside: -52.99%
Maintains: Strong Buy
Price Target: $37$37
Current: $87.97
Upside: -57.94%
Initiates: Outperform
Price Target: $13
Current: $42.27
Upside: -68.46%
Downgrades: Underperform
Price Target: n/a
Current: $31.80
Upside: -